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Can multi-slice computed tomography of the heart
be useful in patients with epicardial leads?
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Abstract
New visualization methods are helpful in the noninvasive diagnosis of heart diseases. How-
ever, sometimes epicardial and endocardial leads can cause problems due to a large number of
artifacts. Based on the presented case, we conclude that it is possible to perform multi-slice
computed tomography of coronary arteries despite the coexistence of transvenous and epicar-
dial leads. (Cardiol J 2013; 20, 1: 87–89)
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The first human implanted cardioverter-
-defibrillator (ICD) was invented in 1980 in Balti-
more by the team of Michel Mirowski, Morton
Mower, and William Staewen [1]. Approval for cli-
nical use was granted by the American Food and
Drug Administration in 1985. Early devices consist-
ed of a pulse generator implanted in the abdominal
cavity and patch electrodes for defibrillation placed
directly on the heart. Implant procedures required
thoracotomy and had a mortality rate of about 4%
[2]. In most implanted patients, an upgrade of the
above characterized system to a transvenous sys-
tem with endocardial leads was performed after
a long period of time.
Multi-slice computed tomography (MSCT) is
a noninvasive method for the visualization of coro-
nary vessels [3]. However, the question as to
whether it is possible to perform MSCT in patients
with epicardial patch electrodes remains current.
We present a case study of an 81 year-old pa-
tient who was implanted in 1987 due to a ventricu-
lar fibrillation (secondary prevention of sudden car-
diac death) with an automated ICD (Ventak-P, Pace-
setters Inc, St. Jude Medical, St. Paul, MN, USA).
The device was implanted to the abdominal cavity
with patch defibrillation leads (no data about the
type of leads was available) placed by thoratocomy.
After a few years, the system was upgraded — the
device was re-implanted to the left subclavian area
using transvenous leads. At the same time, the ICD
was extracted from the abdominal cavity while the
patch leads were left in the heart. Presently, the
patient has Epic TM + VR Model V-196 (St. Jude
Medical, St. Paul, MN, USA), implanted in 2007.
In 2000, the patient had coronaro-angiogra-
phy due to a suspicion of coronary artery disease
(CAD). This suspicion was based on clinical
symptoms such as chest pain, shortness of
breath during vigorous activities, and other typ-
ical/atypical symptoms coexisting. The result of
examination was a subcritical 30% stenosis in
proximal left anterior descending artery. After
ten years (September 2010), we decided to per-
form MSCT of the heart to evaluate progress of
the CAD — insignificant intensification of CAD
clinical symptoms had been observed in the pre-
vious few months. We were afraid that the co-
existence of epicardial and endocardial leads
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might cause significant limitation of the useful-
ness of MSCT.
Computed tomography was performed using
an Aquilion 64 scanner (Toshiba Medical Systems,
Japan). Scanning with retrospective ECG-gating
was performed during a breath-hold using 64 sli-
ces with a collimated slice thickness of 0.5 mm.
A breath-hold examination was performed to ad-
just the scanner settings. The helical pitch was
12.8 in best mode and the rotation time was 0.4 s.
The tube voltage was 135 kV at 380 mA. We used
a pre-selected region of interest in the descend-
ing aorta. Triggering started at 180 Hounsfield
units; 90 mL of non-ionic contrast agent (Ultravist
370, Schering, Germany) was given at a rate of
4.5 mL/s. The contrast agent was given in three
phases: 90 mL of contrast agent (average), then
24 mL of contrast agent followed by 16 mL of sa-
line flush (60%/40%), and finally 30 mL of saline.
During scanning, the patient had native stable
rhythm of 60 bpm.
Reconstructions of data were performed on
Vitrea 2 workstations (Vital Images, Minnetonka, MN,
USA; software version 5.1). Three-dimensional volu-
me rendering reconstructions, and multi planar re-
formatted reconstructions were created.
The result of this examination did not show
progression of changes in the coronaries (Fig. 1).
Artifacts occurred near the leads (Figs. 1B, D). It
was possible to evaluate all coronary arteries with-
out artifacts (Fig. 1C).
An atrial lead (absent in this patient) could con-
stitute a potential problem with right coronary ar-
tery visualization in MSCT [4]. An important obser-
vation is that it was possible to obtain diagnostic
images of coronary arteries despite the presence
of old patch defibrillation leads coexisting with
a transvenous defibrillation lead.
Figure 1. Multi-slice computed tomography (MSCT) images of patient with coexistence of transvenous (active) and
epicardial (not active) leads; A, B. Three-dimensional images of the heart; *visible patch electrodes; C1, C2. Diagno-
stic visualization of the coronaries (LAD — left anterior descending artery, RCA — right coronary artery) despite the
presence of both types of lead; D. Multi planar reformatted reconstruction with visible artifacts from the leads.
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It is possible to perform MSCT of coronary
arteries despite the coexistence of transvenous and
epicardial leads.
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